Genetic initiation of hypertensive and diabetic nephropathy

American Journal of Hypertension

Volumn 11, Issue 2, 1998, Pages 251-257

  Freedman, Barry I ^a   Bowden, Donald W ^a   Rich, Stephen S ^a   Appel, Richard G ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Blacks; Diabetic nephropathy; Genetic linkage analysis; Hypertensive nephrosclerosis

Indexed keywords

DNA;

CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; HYPERTENSION; MOLECULAR GENETICS; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANIMALS; DIABETIC NEPHROPATHIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC;

EID: 0031882735     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00481-0     Document Type: Review

References (54)

1. Brazy PC, Stead WW, Fitzwilliam JF: Progression of renal insufficiency: role of blood pressure. Kidney Int 1989;35:670-674.
2. Brenner BM: Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 1983;23:647-655.
3. Krolewski AS, Warram JH, Christlieb AR: Hypercholesterolemia - a determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int 1994;45:S125-S131.
4. Klahr S, Levey AS, Beck GJ, et al: The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994;339:877-884.
5. Albright F, Baird PC, Cope O, Bloomberg E: Studies on the physiology of the parathyroid glands. IV. Renal complications of hyperparathyroidism. Am J Med Sci 1934;187:49-65.
6. Jeunemaitre X, Soubrier F, Kotevtsev Y, et al: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-180.
7. Caulfield M, Lavender P, Farrell M, et al: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994;330:1629-1631.
8. Hata A, Namikawa C, Sasaki M, et al: Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994;3:1285-1287.
9. Bell GI, Xiang KS, Newman MV, et al: The gene for non-insulin-dependent diabetes mellitus (maturity onset diabetes of the young subtype) is linked to a DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci 1991;88:1484-1488.
10. Froguel P, Vaxillaire M, Velho SF, et al: Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 1992; 356:162-164.
11. Vaxillaire M, Boccio V, Phillip A, et al: A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nature Genet 1995;9:419-423.
12. Bowden DW, Akots G, Rothschild CR, et al: Linkage analysis of maturity onset diabetes of the young (MODY): genetic heterogeneity and non-penetrance. Am J Hum Genet 1992;50:607-618.
13. Freedman BI, Iskandar SS, Appel RG: The link between hypertension and nephrosclerosis. Am J Kidney Dis 1995;25:207-221.
14. Schlessinger SD, Tankersley MR, Curtis JJ: Clinical documentation of end-stage renal disease due to hypertension. Am J Kidney Dis 1994;23:655-660.
15. Pernerger TV, Whelton PK, Klag MJ, Rossiter KA: Diagnosis of hypertensive end-stage renal disease: effect of patient's race. Am J Epidemiol 1995;141:10-15.
16. Flisher D, Franek E, Joest M, et al: Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int 1997;51:1196-1204.
17. Fogo A, Breyer JA, Smith MC, et al: Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American study of kidney disease trial. Kidney Int 1997;51:244-252.
18. Bergman SM, Key BO, Kirk KA, Rostand SG: First-degree relatives of AA with H-ESRD have lower ERPF and GFR associated with normal serum creatinine and urinalysis (abst). J Am Soc Nephrol 1996;7:1577.
19. Campese VM, Parise M, Karubian F, Bigazzi R: Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension 1991;18:805-812.
20. Weir MR, Dengel DR, Behrens T, Goldberg AP: Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension 1995;25: 1339-1344.
21. Weinberger MH, Miller JZ, Luft FC, et al: Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986;8(suppl II):II-127-11-134.
22. Annual Report, Southeastern Kidney Council Inc., ESRD Network 6, 1995.
23. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in nondiabetic subjects. Lancet 1988;ii:530-533.
24. McClellan W, Tuttle E, Issa A: Racial differences in the incidence of hypertensive end-stage renal disease are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 1988;12:285-290.
25. Whittle JC, Whelton PK, Seidler AL, Klag MJ: Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Intern Med 1991;151:1359-1364.
26. Walker WG, Neaton JD, Cutler JA, et al: Renal function change in hypertensive members of the multiple risk factor intervention trial. JAMA 1992;268:3085-3091.
27. Rostand SG, Brown G, Kirk KA, et al: Renal insufficiency in treated essential hypertension. N Engl J Med 1989;320:684-688.
28. Toto RD, Mitchell HC, Smith RD, et al: "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis. Kidney Int 1995;48:851-859.
29. Freedman BI, Spray BJ, Tuttle AB, Buckalew VM Jr: The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 1993;21:387-393.
30. Bergman SM, Key BA, Kirk KA, et al: Kidney disease in the first-degree relatives of African Americans with hypertensive end-stage renal disease. Am J Kidney Dis 1996;27:341-346.
31. Ferguson R, Grim CE, Opgenorth TJ: A familial risk of chronic renal failure among blacks on dialysis? J Clin Epidemiol 1988;41:1189-1196.
32. Freedman BI, Soucie JM, McClellan WM: Family history of end-stage renal disease among incident dialysis patients. J Am Soc Nephrol 1997;8:1942-1945.
33. Zollinger HU, Mihatsch MJ: Renal Pathology in Biopsy: Berlin-Heidelberg, Springer-Verlag, 1978, pp 391-399.
34. Nelson RG, Newman JM, Knowler WC, et al: Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1988;31:730-736.
35. Mogensen CE: Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987;31:673-689.
36. Warram JH, Gearin G, Laffel L, Krolewski AS: Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/ creatinine ratio. J Am Soc Nephrol 1996;7:930-937.
37. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
38. Viberti G, Mogensen CE, Groop LC, Pauls JH: Effect of Captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994;271:275-279.
39. Borch-Johnsen K, Norgaard K, Hommel E, et al: Is diabetic nephropathy an inherited complication? Kidney Int 1992;41:719-722.
40. Seaquist ER, Goetz FC, Rich SS, Barbosa J: Familial clustering of diabetic kidney disease: evidence of genetic susceptibility to diabetic nephropathy. N Engl J Med 1989;320:1162-1165.
41. Petitt DJ, Saad MJ, Bennett PH, et al: Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1990;33:438-443.
42. Freedman BI, Tuttle AB, Spray BJ: Familial predisposition to nephropathy in African Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1995;25:710-713.
43. Krolewski AS, Canessa M, Warram JH, et al: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988;318:140-145.
44. Strojek K, Grzeszczak W, Morawin E, et al: Nephropathy of type II diabetes: evidence for hereditary factors? Kidney Int 1997;51:1602-1607.
45. Quinn M, Angelico MC, Warram JH, Krolewski AS: Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996;39:940-945.
46. Freedman BI, Wilson CH, Spray BJ, et al: Familial clustering of end-stage renal disease in African-Americans with lupus nephritis. Am J Kidney Dis 1997;29:729-732.
47. Simon B, Farhi A, Mahnensmith R, Lifton RP: Inherited susceptibility to HIV nephropathy in African Americans (abst). J Am Soc Nephrol 1996;7:1343.
48. Lei HH, Perneger TV, Klag MJ, et al: Is the association between family history of renal disease and end-stage renal disease explained by concurrent aggregation of risk factors? (abst). J Am Soc Nephrol 1996;7:1322.
49. Brown DM, Provoost AP, Daly MJ, et al: Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nature Genet 1996;12:44-51.
50. Suarez BK, Rice J, Reich T: The generalized sib pair IBD distribution: its use in the detection of linkage. Ann Hum Genet 1978;42:87-94.
51. Lathrop GM, Lalouel JM, Julier C, Ott J: Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 1984;81:3443-3446.
52. Bowden DW, Sale M, Howard TD, et al: Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sibpairs with a history of diabetic nephropathy. Diabetes 1997;46:882-886.
53. Yu H, Bowden DW, Spray BJ, et al: Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans. J Am Soc Nephrol 1996;7:2559-2564.
54. Freedman BI, Yu H, Spray BJ, et al: Genetic linkage of growth factor loci and end-stage renal disease in African Americans. Kidney Int 1997;51:819-825.